Evidence map›Paper›PMID 35695982›Full record

ArticleGeroScience2022

Evidence that conserved essential genes are enriched for pro-longevity factors.

Naci Oz, Elena M Vayndorf, Mitsuhiro Tsuchiya, Samantha McLean, Lesly Turcios-Hernandez, Jason N Pitt, Benjamin W Blue, Michael Muir, Michael G Kiflezghi, Alexander Tyshkovskiy and 3 more

Open access · hybridAbstract read
In one paragraph

Article in GeroScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Pattern recognition in the landscape of seemingly random chimeric transcripts.Computational and structural biotechnology journal · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Naci OzDepartment of Biology, Virginia Commonwealth University, Richmond, VA, 23284, USA.
Elena M VayndorfDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98195, USA.
Mitsuhiro TsuchiyaDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98195, USA.
Samantha McLeanDepartment of Biology, Virginia Commonwealth University, Richmond, VA, 23284, USA.
Lesly Turcios-HernandezDepartment of Biology, Virginia Commonwealth University, Richmond, VA, 23284, USA.
Jason N PittDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98195, USA.
Benjamin W BlueDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98195, USA.
Michael MuirDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98195, USA.
Michael G KiflezghiDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98195, USA.
Alexander TyshkovskiyDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Alexander MendenhallDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98195, USA.
Matt KaeberleinDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 98195, USA. kaeber@uw.edu.
Alaattin KayaDepartment of Biology, Virginia Commonwealth University, Richmond, VA, 23284, USA. kayaa@vcu.edu.ORCID 0000-0002-6132-5197
University of Washington · USVirginia Commonwealth University · USBrigham and Women's Hospital · US

Funding

University of Washington Nathan Shock Center of Excellence in the Basic Biology of AgingP30AG013280 · NIA · UNIVERSITY OF WASHINGTON · PI Michael MacCoss · 1995 to 2026
$27.1M
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
Biological Mechanisms of Healthy Aging Training GrantT32AG066574 · NIA · UNIVERSITY OF WASHINGTON · PI David J. Marcinek, Jessica E Young · 2020 to 2026
$5.3M
Understanding the antagonistic role of proteostasis in Alzheimer disease and cancer.R01CA219460 · NCI · UNIVERSITY OF WASHINGTON · PI MENDENHALL, ALEXANDER RICHARD · 2018 to 2022
$2.2M
MOLECULAR MECHANISMS OF NATURAL LIFESPAN VARIATIONK01AG060040 · NIA · VIRGINIA COMMONWEALTH UNIVERSITY · PI KAYA, ALAATTIN · 2019 to 2022
$515k
NCI NIH HHS R01 CA219460NIA NIH HHS K01 AG060040NIA NIH HHS P30 AG013280NIA NIH HHS T32 AG052354NIA NIH HHS T32 AG066574
6 · The paper itself

Abstract

At the cellular level, many aspects of aging are conserved across species. This has been demonstrated by numerous studies in simple model organisms like Saccharomyces cerevisiae, Caenorhabdits elegans, and Drosophila melanogaster. Because most genetic screens examine loss of function mutations or decreased expression of genes through reverse genetics, essential genes have often been overlooked as potential modulators of the aging process. By taking the approach of increasing the expression level of a subset of conserved essential genes, we found that 21% of these genes resulted in increased replicative lifespan in S. cerevisiae. This is greater than the ~ 3.5% of genes found to affect lifespan upon deletion, suggesting that activation of essential genes may have a relatively disproportionate effect on increasing lifespan. The results of our experiments demonstrate that essential gene overexpression is a rich, relatively unexplored means of increasing eukaryotic lifespan.

Indexed as

LongevitySaccharomyces cerevisiaeAgingAnimalsDrosophila melanogasterGenes, EssentialAgingC. elegansEssential geneOrthologsS. cerevisiae

Identifiers

PMID35695982
PMCPMC9616985
OpenAlexW4282564221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.